Literature DB >> 3659257

Lupus nephritis: clinical and pathological correlation.

B Leaker1, K F Fairley, J Dowling, P Kincaid-Smith.   

Abstract

The clinical course of 135 patients with lupus nephritis was examined long-term as part of a prospective study. Biopsies were classified according to modified WHO criteria and showed 17 per cent of patients had mild mesangial lesions, 10 per cent focal lesions, 21 per cent mild diffuse proliferative lesions, 37 per cent severe diffuse proliferative lesions and 15 per cent membranous lesions. Overall patient survival of 83 and 65 per cent at five and 10 years respectively from onset of nephritis was similar to other recently published series. In contrast to the latter, the severe proliferative group had a significantly worse outcome than the other proliferative groups (p less than 0.01) and only patients in this group progressed to end-stage renal failure. Haematuria was more common (p less than 0.05) in the severe group and there was a striking correlation between histologic activity assessed semiquantitatively (Table 1) and urinary red cell count (p less than 0.001). There was no correlation between serum creatinine, proteinuria or chronic lesions with urinary red cell count. In contrast to a previous study there was no correlation between the presence of hyaline thrombi on initial biopsy and subsequent development of glomerular sclerosis. Although the value of renal biopsy has been questioned, we suggest that it remains a most important investigation in the management of lupus nephritis. Determination of urinary red cell count provides a most useful monitor of disease activity and response to treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3659257

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  13 in total

Review 1.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Deterioration of renal function in a patient with lupus.

Authors:  E C Rankin; G H Nield; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

3.  The significance of arterial hypertension at the onset of clinical lupus nephritis.

Authors:  I P Naiker; V Chrystal; I G Randeree; Y K Seedat
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

Review 4.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 5.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.

Authors:  Chi Chiu Mok
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

Review 6.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Renal biopsy pathology in a cohort of patients from southwest Sydney with clinically diagnosed systemic lupus erythematosus.

Authors:  Jim Lc Yong; Murray C Killingsworth; Ken Lai
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-02-13

8.  Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study.

Authors:  Titilayo O Ilori; Nosayaba Enofe; Anju Oommen; Jason Cobb; Jose Navarrete; Demilade A Adedinsewo; Oluwatobiloba Oshikoya; Helene Fevrier; Alton B Farris; Laura Plantinga; Akinlolu O Ojo
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

9.  Serum alpha-actinin antibody status in systemic lupus erythematosus and its potential in the diagnosis of lupus nephritis.

Authors:  Mansour Babaei; Zahra Rezaieyazdi; Nayereh Saadati; Massoud Saghafi; Maryam Sahebari; Bahram Naghibzadeh; Habibollah Esmaily
Journal:  Caspian J Intern Med       Date:  2016

10.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.